library.onepin.app/ghrp-6 Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Growth Hormone Synthetic hexapeptideNot FDA-approved · research compound

GHRP-6

GHRP6

100 mcg – 100-150 mcg SubQ 1-3 times daily
300 mcg/kg Oral Single administration
Ghrelin receptor agonistGrowth hormone releasing peptideStrong appetite stimulant

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide ghrelin receptor agonist that produces the strongest appetite stimulation of any GHRP. It was one of the earliest GHRPs discovered and produces robust GH release but with pronounced hunger, cortisol elevation, and prolactin elevation compared to Ipamorelin. GHRP-6 is primarily used when appetite stimulation is a desired therapeutic goal (wasting conditions, difficulty eating) or when maximum GH output is needed regardless of side effects.

Quick Start
Route
SubQ injection
Start low
100 mcg SubQ
Frequency
1-3 times daily
Timing
Fasted. Extreme hunger follows.

Fasted 2+ hours. Bedtime or pre-meal (causes strong hunger). Can split into 2-3 daily doses. Strongest ghrelin receptor agonist.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
100 mcg · SubQ injection · 1-3 times daily
conservative starter
100 mcg
1-3 times daily
Standard
Appetite & Recovery
100-150 mcg · SubQ · 3x Daily
anecdotal · community
Potent ghrelin-receptor agonist - intense hunger ~15-30 min post-dose. Favored for bulking; usually paired with a GHRH.
100-150 mcg
3x Daily
Research
GH-Provocation Test (single dose)
300 mcg/kg · Oral · Single administration
human study · Mericq et al. 1995 (Eur J Endocrinol 133(4):425, PMID 7581965)
300 mcg/kg
Single administration
Reconstitution CalculatorU-100
050100u
Draw to
units
01

How it works

GHRP-6 activates GHS-R1a with strong ghrelin-mimetic activity, producing both GH release and potent appetite stimulation through hypothalamic hunger signaling. More cortisol and prolactin elevation than GHRP-2 or Ipamorelin. The hunger effect is often dramatic and occurs within 15-20 minutes of injection.

02

What to expect

Early
Days 1–7

Immediate: Extreme hunger. Days 1-7: Sleep improvements, body composition changes beginning.

Mid
Weeks 2–4

Weeks 2-6: Continued GH effects.

Later
Weeks 4–12

Weeks 6+: Full body composition effects with GHRH analog.

03

Evidence

HumanPresent
AnimalStrong
In-vitroPresent

Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.

GHRP-6 has potent GH-releasing activity after IV, SubQ, intranasal, and oral administration in humans.

Growth hormone-releasing peptide 6 (GHRP-6) is a synthetic hexapeptide with a potent GH-releasing activity after intravenous, subcutaneous, intranasal and oral administration in man.

Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature. European journal of endocrinology · 1995 · PMID 7581965

Evidence scope. Human child short-stature paper; tested dose was oral, not quick-start SubQ.

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Dose/frequency: 100 mcg SubQ 1-3x/day. No checked abstract stated a SubQ dose.

Extreme hunger and cortisol/prolactin at this dose. No exact-molecule abstract established these at the displayed regimen.

04

The honest take

Strongest appetite GHRP

Confirmed. Most potent ghrelin-mediated hunger of any GHRP. Therapeutic advantage in cachexia/wasting.

05

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

BPC-157Non-overlapping
VIPNo conflict
CJC-1295 no DACGHRP + GHRH synergy.
SermorelinGHRP + GHRH synergy.

Keep separate

TesamorelinUse Ipamorelin with Tesa in standard protocols.
CJC-1295 with DACDAC maleimide.

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

06

Side effects & safety

Commonly reported

  • Extreme hunger (defining feature)
  • Water retention
  • Cortisol elevation
  • Prolactin elevation
  • Lethargy

Less common & notes

  • Anxiety, sleep disruption.
  • Prolactin gynecomastia risk at high doses.
  • Cortisol effects more pronounced than other GHRPs.
07

Pharmacokinetics

Illustrative plasma concentration · 1.6 h
Half-life
0.33h
Peak · Tmax
0.25h
Elimination
1.65h
Bioavailability
~100%

SubQ

Duration of action
4-6 hours

GH pulse lasts 2-3 hours; appetite stimulation persists 1-2 hours

Clearance

Enzymatic degradation and renal clearance

Storage. Standard BAC water 2-8C. 28 days.

08

Regulatory status

Not FDA-approved. WADA prohibited under S2.

Put it to work

Calculate, log & track

Open GHRP-6 straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open GHRP-6 in the app →

Go deeper

The guide & community

The complete GHRP-6 walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.